Vedanta Presents Data from Multiple Studies at Digestive Disease Week 2022 Annual Meeting | Business Wire
CAMBRIDGE, Mass.–(BUSINESS WIRE)–Vedanta Biosciences, a clinical-stage biopharmaceutical company pioneering the development of oral therapies based on defined bacterial consortia, today announced the details of three podium presentations of research informed…
Read More »